Anti-Human IL‑23 p19 Reference Antibody (Risankizumab, RUO)

Catalog No.	HV466016
Host species	Humanized
Species reactivity	Human
Form	Liquid
Storage buffer	0.01M PBS, pH 7.4.
Purity	>95% purity as determined by SDS-PAGE.
Clonality	Monoclonal
Isotype	IgG1-kappa
Applications	ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Target	SGRF, IL-23-A, IL-23 subunit alpha, Interleukin-23 subunit p19, IL23A, Interleukin-23 subunit alpha, IL-23p19
Purification	Protein A/G purified from cell culture supernatant.
Endotoxin level	Please contact the lab for this information.
Expression system	Mammalian Cells
Accession	Q9NPF7
Stability and Storage	Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Alternative name	BI655066, risankizumab-rzaa, 1612838-76-2
Note	For research use only. Not suitable for clinical or therapeutic use.

Bioactivity	SEC-HPLC detection for Research Grade Risankizumab.
SDS-PAGE	SDS-PAGE for Research Grade Risankizumab.
Western blot	Western blot analysis was performed using anti-IL23A monoclonal antibody at 1ug/mL on various samples. Lane 1: recombinant human IL23A (Catalog No: HV466011) Lane 2: negative control
Bioactivity	Detects IL23A in indirect ELISA